Teva Pharmaceutical Industries Ltd (TEVA)
16.26
+0.26
(+1.59%)
USD |
NYSE |
May 10, 16:00
16.28
+0.02
(+0.15%)
After-Hours: 20:00
Teva Pharmaceutical Industries Revenue (TTM): 16.00B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 16.00B |
December 31, 2023 | 15.85B |
September 30, 2023 | 15.27B |
June 30, 2023 | 15.02B |
March 31, 2023 | 14.92B |
December 31, 2022 | 14.92B |
September 30, 2022 | 15.14B |
June 30, 2022 | 15.43B |
March 31, 2022 | 15.56B |
December 31, 2021 | 15.88B |
September 30, 2021 | 16.23B |
June 30, 2021 | 16.32B |
March 31, 2021 | 16.28B |
December 31, 2020 | 16.66B |
September 30, 2020 | 16.67B |
June 30, 2020 | 16.79B |
March 31, 2020 | 17.09B |
December 31, 2019 | 16.88B |
September 30, 2019 | 16.39B |
June 30, 2019 | 16.83B |
March 31, 2019 | 17.35B |
December 31, 2018 | 18.27B |
September 30, 2018 | 19.16B |
June 30, 2018 | 20.25B |
March 31, 2018 | 21.27B |
Date | Value |
---|---|
December 31, 2017 | 21.85B |
September 30, 2017 | 23.48B |
June 30, 2017 | 23.42B |
March 31, 2017 | 22.74B |
December 31, 2016 | 21.90B |
September 30, 2016 | 20.29B |
June 30, 2016 | 19.55B |
March 31, 2016 | 19.48B |
December 31, 2015 | 19.65B |
September 30, 2015 | 19.94B |
June 30, 2015 | 20.17B |
March 31, 2015 | 20.25B |
December 31, 2014 | 20.27B |
September 30, 2014 | 20.53B |
June 30, 2014 | 20.54B |
March 31, 2014 | 20.41B |
December 31, 2013 | 20.31B |
September 30, 2013 | 20.13B |
June 30, 2013 | 20.05B |
March 31, 2013 | 20.12B |
December 31, 2012 | 20.32B |
September 30, 2012 | 20.74B |
June 30, 2012 | 20.12B |
March 31, 2012 | 19.33B |
December 31, 2011 | 18.31B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.92B
Minimum
Dec 2022
17.09B
Maximum
Mar 2020
16.01B
Average
16.12B
Median
Revenue (TTM) Benchmarks
Viatris Inc | 15.43B |
Alvotech | 91.43M |
AstraZeneca PLC | 47.61B |
Corcept Therapeutics Inc | 523.53M |
GSK PLC | 38.64B |